RESPONSES TO 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN ADULTS 70–79 WITH CHRONIC DISEASES

Many countries recommend that adults with chronic disease be vaccinated with pneumococcal polysaccharide vaccine (PPSV23) because of their increased risk for pneumococcal disease. To explore the immunogenicity of PPSV23 in these patients we examined antibody responses in adults age 70–89 with chroni...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Innov Aging
Asıl Yazarlar: Kawakami, K., Kishino, H., Kanazu, S., Toshimizu, N., Yokokawa, R., Takahashi, K., Kohn, M., Musey, L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6242514/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/geroni/igx004.788
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller